Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology
(1999) In Journal of Rheumatology 26(2). p.484-489- Abstract
- Observational and longitudinal observational studies (LOS) provide essential information about the course and outcome of rheumatic disorders that cannot be provided by randomized controlled trials, and they constitute the major clinical scientific communication in rheumatology. There has been no consensus as to the full and appropriate content of LOS. This report defines a core set of domains and reporting requirements for LOS. At the 1998 OMERACT IV Conference a consensus process evaluated the literature of rheumatology in light of the constructs, variables, and outcomes of rheumatology by using introductory lectures, nominal groups, and plenary sessions. The result of this process was to identify 5 "core" domains that should be included... (More)
- Observational and longitudinal observational studies (LOS) provide essential information about the course and outcome of rheumatic disorders that cannot be provided by randomized controlled trials, and they constitute the major clinical scientific communication in rheumatology. There has been no consensus as to the full and appropriate content of LOS. This report defines a core set of domains and reporting requirements for LOS. At the 1998 OMERACT IV Conference a consensus process evaluated the literature of rheumatology in light of the constructs, variables, and outcomes of rheumatology by using introductory lectures, nominal groups, and plenary sessions. The result of this process was to identify 5 "core" domains that should be included in every LOS: Health Status, Disease Process, Damage, Mortality, and Toxicity/Adverse Reactions. Two additional domains, Work Disability and Costs, were recognized as important, but need not be used in all LOS. Eleven subdomains were identified that divided the domains into convenient clinical and conceptual units. A set of reporting requirements was also determined. The core recommendations, which follow on the WHO ICIDH-2 outline, are not disease-specific; the substitution of different "disease process" and "damage" measures make them suitable for many rheumatic disorders. The core set is intended to serve as a core for LOS in almost all rheumatic conditions. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1115823
- author
- organization
- publishing date
- 1999
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Diseases of the osteoarticular system, Rheumatology, Evaluation, Clinical trial, Prognosis, Follow up study, Methodology, Human
- in
- Journal of Rheumatology
- volume
- 26
- issue
- 2
- pages
- 484 - 489
- publisher
- Journal of Rheumatology Publishing Company Limited
- external identifiers
-
- pmid:9972992
- scopus:0032948151
- ISSN
- 0315-162X
- language
- English
- LU publication?
- yes
- id
- 4bf68102-1cab-457f-b069-d6a5b4e122fe (old id 1115823)
- date added to LUP
- 2016-04-01 12:21:25
- date last changed
- 2022-01-27 02:37:35
@article{4bf68102-1cab-457f-b069-d6a5b4e122fe, abstract = {{Observational and longitudinal observational studies (LOS) provide essential information about the course and outcome of rheumatic disorders that cannot be provided by randomized controlled trials, and they constitute the major clinical scientific communication in rheumatology. There has been no consensus as to the full and appropriate content of LOS. This report defines a core set of domains and reporting requirements for LOS. At the 1998 OMERACT IV Conference a consensus process evaluated the literature of rheumatology in light of the constructs, variables, and outcomes of rheumatology by using introductory lectures, nominal groups, and plenary sessions. The result of this process was to identify 5 "core" domains that should be included in every LOS: Health Status, Disease Process, Damage, Mortality, and Toxicity/Adverse Reactions. Two additional domains, Work Disability and Costs, were recognized as important, but need not be used in all LOS. Eleven subdomains were identified that divided the domains into convenient clinical and conceptual units. A set of reporting requirements was also determined. The core recommendations, which follow on the WHO ICIDH-2 outline, are not disease-specific; the substitution of different "disease process" and "damage" measures make them suitable for many rheumatic disorders. The core set is intended to serve as a core for LOS in almost all rheumatic conditions.}}, author = {{Wolfe, F and Lassere, M and van der Heijde, D and Stucki, G and Suarez-Almazor, M and Pincus, T and Eberhardt, Kerstin and Kvien, T K and Symmons, D and Silman, A and van Riel, P and Tugwell, P and Boers, M}}, issn = {{0315-162X}}, keywords = {{Diseases of the osteoarticular system; Rheumatology; Evaluation; Clinical trial; Prognosis; Follow up study; Methodology; Human}}, language = {{eng}}, number = {{2}}, pages = {{484--489}}, publisher = {{Journal of Rheumatology Publishing Company Limited}}, series = {{Journal of Rheumatology}}, title = {{Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology}}, volume = {{26}}, year = {{1999}}, }